Devis Gobbi

Senior Competitive And Business Intelligence Analyst, Strategic Alliances & Partnerships at Evotec

Devis Gobbi is a seasoned professional currently serving as a Senior Competitive and Business Intelligence Analyst in Strategic Alliances & Partnerships at Evotec since October 2021. With extensive experience at Aptuit, starting in July 2010, Devis has held positions as a Senior Business Analyst, CRM Administrator, and Sales Analyst, focusing on enterprise sales reporting and commercial analytics across multiple global facilities. Prior to this, Devis worked at GlaxoSmithKline from July 1996 to July 2010 as a Support Manager and Helpdesk Coordinator, managing the life-cycle of over 3000 devices and overseeing software management. Educational qualifications include a Project Management degree from Bologna Business School, an MBA from the London School of Business and Finance, a degree in Sales Planning from SDA Bocconi, and training in Strategic Selling Funnel Management from the Miller Heiman Group Academy.

Location

Verona, Italy

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Evotec

5 followers

Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.


Industries

Headquarters

Hamburg, Germany

Employees

1,001-5,000

Links